I agree there is always a chance of a share price explosion for Peregrine. Bavi is approved for Phase III, and a partner or buyer could pop up any time.
Meanwhile I doubt the FDA has the resources or mandate to review the odd results from the front line NSCLC trial.
I am more interested in the still running lung cancer trial with permetrexed or whatever it was. I am also very interested in the results from the liver cancer trial. Either one of these could give the SP a much needed jolt.